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Demonstrating T-cell clonality has become an important
approach supporting a diagnosis of malignant T-cell
neoplasms. A comparative study between Genescan
analysis, polyacrylamide gel and agarose gel electro-
phoresis in visualizing T-cell receptor gamma gene
rearrangement was performed on 25 biopsy specimens
from 18 patients with different forms of cutaneous T-cell
lymphomas. Clonality was detected in 17 biopsy speci-
mens when PCR products were evaluated by Genescan
analysis. Seventeen showed discrete bands when visua-
lized in polyacrylamide gel and 14 cases were clonal when
visualized with agarose gel. In five cases, a clonal
population was seen in the gels, but not with Genescan.
On sequencing the PCR products we demonstrated non-
clonality of these five samples. Our results confirm that
PCR-Genescan is a useful, reliable and specific screening
method for detecting dominant clones in patients with
T-cell lymphoma. Key words: Genescan; PCR; poly-
acrylamide gel electrophoresis and agarose gel electro-
phoresis; T-cell clonality.
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During recent years, several different polymerase chain
reaction (PCR) assays have been claimed as specific and
sensitive methods for assessing clonality in T-cell
lymphoproliferative disorders (1). The different PCR
methods usually vary in the selection of oligonucleotide
primers for amplification of DNA fragments of the
T-cell receptor-c (TCR-c) or b (TCR-b) subunits and in
the screening techniques used to detect the amplicons.
PCR technology, in contrast to Southern blot, is a
rapid and easy method that does not require radio-
actively labelled probes and permits detection of less
than 1 – 5% of clonal cells. In addition, very small
amounts of DNA obtained from routinely processed,
formalin-fixed, paraffin-embedded tissue samples can
be analysed with good results (2).
Ethidium bromide-stained agarose gel (AGGE) and
polyacrylamide gel electrophoresis (PAGE) are com-
monly used techniques for visualizing PCR products in
routine diagnosis (3, 4). However, they have low
separation capacity, especially agarose, which prevents
reliable discrimination between clonal and non-clonal
PCR products. Among techniques with a higher
resolution for determining dominant T-cell clones are
denaturing gradient gel electrophoresis (DGGE), tem-
perature gradient gel electrophoresis (TGGE) and
automated fluorescent fragment analysis by Genescan
(GSA), which are currently used by leading groups.
GSA is a new method for determining dominant T-cell
clones and is more accurate, specific and easy to
interpret than AGGE and PAGE (5 – 8). Despite its
unquestionable diagnostic interest, however, the defini-
tive role of PCR-GSA amplification of the TCR-c
technique in the routine diagnostic evaluation of CTCL
has not been clearly defined.
The aim of this study was to compare PCR-GSA
with the conventional PCR-AGGE and PCR-PAGE in
the detection of clonal T-cell predominance in cuta-
neous T-cell lymphoproliferative disorders (CTCL).
MATERIALS AND METHODS
Twenty-five skin biopsies from 18 patients with a proven
diagnosis of CTCL were studied for genotypic analysis (PCR
analysis of TCRc) at the Laboratory of Cytogenetics and
Molecular Biology, Pathology Department, Hospital del Mar
in Barcelona, Spain.
The diagnosis was established on the basis of clinical data,
routine histopathologic examination and immunophenotypic
expression according to standard criteria for the diagnosis
of primary cutaneous T-cell lymphoma of the EORTC
classification (9).
Histopathologic features were diagnosed as advanced stage
mycosis fungoides (MF) in six biopsies. Eight biopsies were
obtained from small-medium sized CD30 negative T-cell
pleomorphic lymphoma (SM-TCL), 10 biopsy specimens cor-
responding to plaque stage MF, 7 of them were from patients
with extensive disease, and one patient had lymphomatoid
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papulosis (LyP). In seven patients more than one biopsy from
different lesions was analysed. All biopsy samples were
obtained simultaneously for histopathologic and molecular
diagnostic purposes and were stored at 270‡C. In addition,
peripheral blood samples from seven normal donors and a
series of seven skin paraffin-embedded biopsies from patients
affected by psoriasis were also studied as controls.
Immunohistochemical studies
Immunohistochemical studies were performed in all cases
using formalin-fixed paraffin-embedded tissue sections with
en-Vision technique in an automated immunostainer, using
the antibodies CD3, CD8, CD20, CD30 (Dako, Glostrup,
Denmark), CD4 and CD56 (Novocastra, Newcastle, UK).
DNA extraction
DNA from fresh tissue was isolated by cell lysis, phenol-
chloroform extraction and ethanol precipitation according to
standard procedures. For polyclonal skin controls, the DNA
was extracted from paraffin-embedded biopsies using a Kit
QIAamp Tissue Kit (QIAGEN GmbH, Hilden, Germany)
and from peripheral blood lymphocytes of healthy donor
samples using salt extraction and ethanol precipitation
according to standard procedures.
PCR amplification
Genomic DNA (200 ng) was amplified in a semi-nested PCR
as previously described (5). The initial amplification was
performed using the following oligonucleotide primers:
Vc11 – 9 (5’-TGC AGC CAG TCA GAA ATC TTC C 3’),
JGT3 (5’AGT TAC TAT GAG C(CT) AGT CCC 3’) and
JGT1/2 (5’AAG TGT TGT TCC ACT GCC AAA 3’). The
second amplification was performed using the following
oligonucleotide primers: JGT3, JGT1/2 and Vc21 – 9 (5’ACG
GCG TCT TC(AT) GTA CTA TGA C 3’) labelled with
FAM.
TCR-c PCR-GSA analysis was performed in triplicate for
each skin biopsy to avoid the false-positive interpretation of
monoclonality (pseudomonoclonality).
Fluorescent fragments analysis (Genescan)
One microlitre of a 1:10 dilution of the PCR product was
mixed with 9 ml of deionized formamide (Applied Biosystems,
Foster City, CA) and 0.5 ml of molecular weight standard
(Genescan 400-ROX, Applied Biosystems). Samples were
analysed by automated fragment ABI 3100 (Genescan
system).
A case was assigned as monoclonal when only one or two
peaks with appropriate size range were seen and the size of
the peaks was similar to 200 bp in all PCRs. Polyclonal cases
showed multiple peaks of approximately 200 bp. In all cases a
repeated determination was performed routinely.
Agarose gel electrophoresis analysis (AGGE)
Twenty microlitres of PCR products were simultaneously
analysed in a 2% AGGE. Samples analysed were considered
as monoclonal if one or two discrete narrow bands were
observed within the appropriate size range expected for a
particular primer pair. The result was considered correct if it
was reproducible on duplicate runs. In contrast, polyclonal
samples appeared as a broad smear.
Polyacrylamide gel electrophoresis analysis (PAGE)
Twenty microlitres of PCR products were analysed in 8%
PAGE stained with ethidium bromide. The criteria for
considering a sample monoclonal or polyclonal were the
same as those described for analysis by agarose gel
electrophoresis.
Sequencing of PCR products
When sequencing was performed, the second amplification
was done with non-labelled Vc21 – 9 primer. The PCR product
was purified using a QIAquick PCR purification kit
(QIAGEN). One microlitre of the purification product was
subjected to fluorescent dye terminator cycle sequencing. The
PCR product was purified with Centrisep, Priceton separa-
tions spin columns (Applied Biosystem) and analysed on
DNA sequencing analysis software 3.7 (Applied Biosystem).
In cases in which visualization of the PCR product with GSA,
PAGE and AGGE was divergent, direct sequencing of the
PCR products was routinely performed.
PCR sensitivity
To determine the sensitivity of the technique, DNA from a
skin biopsy of a patient with a monoclonal pattern was
serially diluted (1:1, 1:10, 1:50, 1:100, 1:500) with DNA from
a normal donor with a polyclonal pattern.
Internal DNA controls
Amplification of exon 3 of the human b-actin gene was used
as internal control of DNA integrity.
RESULTS
In 25 biopsies from the 18 CTCL diagnosed cases,
TCR-c GSA revealed a dominant clone in 17 biopsies
(68%) (Table I). We failed to demonstrate a specific
clone in eight biopsies (32%) with undoubtful histologic
diagnostic and immunophenotypic expression being
CD4 positive and CD56 negative (data not shown). The
PCR product was simultaneously run onto AGGE and
PAGE gels. The results of this study demonstrated that
17 out of 25 biopsies analysed (68%) showed discrete
bands by PAGE. When the PCR products were
visualized using AGGE, only 14 of 25 biopsies (56%)
showed a distinctive band that was interpreted as
monoclonal (Figs. 1 – 2).
Looking at different diagnosis, clonality was demon-
strated in 5 out of 8 biopsies (62%) from SM-TCL, and
in 11 out of 16 biopsies of MF (69%) using GSA.
Analysing the same PCR product with PAGE and
AGGE, 6 and 5 biopsies, respectively, showed distinct
bands for the SM-TCL group. Among 16 biopsies of
MF, 11 sharp bands were seen in PAGE (69%) and 9
biopsies were considered as clonal by AGGE (56%).
One patient had LyP coexisting with MF and the
PCR revealed clonality when visualized with GSA. It
was not possible to confirm this clonal population with
AGGE or PAGE. It is remarkable that in this case an
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identical peak of rearranged TCR-c genes was observed
by GSA for the MF and LyP biopsies.
In cases 3, 6, 8, 10, 13, 17 and 18, two skin samples
were obtained from different cutaneous lesions and an
identical rearranged pattern was detected by GSA. In
cases 6, 7, 13 and 16 we detected a discrete band by
PAGE and AGGE; however, GSA revealed a poly-
clonal population. In these cases, sequencing of the
PCR products was crucial to determining the non-
clonality of the samples. Moreover, in cases 8, 15, 17
and 18, which had a clear clonal peak by GSA but not
with PAGE and AGGE, clonality was verified by direct
sequencing.
All samples from healthy donors and lesions of
psoriasis showed clear polyclonal amplification patterns
of TCR-c with no difference in interpretation of GSA,
PAGE and AGGE.
The methodological sensitivity of our PCR method
for detecting a clonal TCR gene rearrangement on skin
biopsies was approximately 2% (1:50 dilution) using
GSA and 10% (1:10 dilution) using AGGE and PAGE
(Fig. 3).
Table I. Results of the PCR-TCR-c gene rearrangement
from 25 biopsies of primary cutaneous T-cell lymphoprolife-
rative disorders visualized by Genescan analysis (GSA),
polyacrylamide gel electrophoresis (PAGE) and ethidium








1 SM-TCL T3N1M1 z z z
2 SM-TCL T3N0M0 2 2 2
3 SM-TCL T3N1M0 z z z
SM-TCL T3N1M0 2 z* z*
4 SM-TCL T3N0M1 z z 2
5 SM-TCL T3N0M1 z z z
6 SM-TCL T3N0M0 2 z* z*
SM-TCL T3N0M0 2 2 2
7 MF T3N0M0 2 z* z*
8 MF T3N0M0 z 2 2
MF T3N0M0 z z z
9 MF T3N1M0 2 2 2
10 MF T3N1M1 z z 2
MF T3N1M1 z z z
11 MF T2N0M0 z z z
12 MF T2N0M0 z z z
13 MF T2N0M0 2 z* z*
MF T2N0M0 2 z* z*
14 MF T2N2M0 z z z
15 MF T2N0M0 z 2 2
16 MF T2N0M0 2 z* z*
17 MF T1N0M0 z z 2
MF T1N0M0 z 2 2
18 MF T1N0M0 z 2 2
LyP – z 2 2
*To determine the possible false-positive results visualizing the PCR
with AGGE and PAGE, direct sequencing was performed to demon-
strate the non-clonality of the sample.
MF~mycosis fungoides; SM-TCL~small-medium sized CD30 nega-
tive T-cell pleomorphic lymphoma; LyP~lymphomatoid papulosis.
Fig. 1. Study of the TCR-c gene rearrangement using PCR-GSA.
A predominant clone is observed in lanes 1, 3 and 5 (patients
no. 1, 3 (first biopsy), 5). Lanes 2, 6 and 7 (patients no. 2, 6 (first
biopsy), 7) show a polyclonal pattern. Lane 8 is the polyclonal con-
trol, lane 9 is the negative control and lane 10 the positive control.
The X-axis shows the size in bp (base pairs) of the PCR product
and Y-axis the intensity of fluorescence) (arbitrary units).
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DISCUSSION
Detection of lymphoid clonality in clinical specimens
by PCR analysis has become a useful and reliable
technique in the diagnosis of cutaneous malignant
lymphomas. Some studies have reported the use of
PCR for amplification of a conserved sequence of the
variable and joining region segments of the TCRc gene
(3, 4, 10 – 19). PCR products can be separated based on
PAGE (3, 4), on DGGE (20) or TGGE (6, 7, 21), by
analysis of single-stranded conformational polymorph-
isms (15, 22), lightcycler-PCR (23), by heteroduplex
analysis (6, 7, 10, 14, 24) or by fragment analysis (5 – 8,
25). With these techniques, a monoclonal T-cell popula-
tion can be detected in between 59% and 100% of
CTCLs (23).
PCR-GSA is a novel, simple and rapid test with an
overall low cost and theoretical major advantage over
other methods for detecting TCR-c and IgH chain gene
rearrangements (5, 25, 26). PCR products are visualized
as monoallelic peaks of fluorescence with high resolution
of fragment size. Accuracy in determining the size of
the PCR products and the ability to distinguish
between polyclonal and monoclonal DNA patterns
Fig. 2. Study of the TCR-c gene rearrangement using PAGE and AGGE to visualize the PCR product (see Table I and Fig. 1 for abbrevia-
tions). The results are the same except for lane 7, which was polyclonal using GSA, see Fig. 1, and clonal with PAGE and AGGE. In this
case it was necessary to sequence the PCR product to determine the non-clonality of the sample.
Fig. 3. Sensitivity of the technique using AGGE (1), PAGE (2) or GSA (3) to visualize the PCR products (see Table I for abbreviations).
Serial dilutions (1:1, 1:10, 1:50, 1:100, 1:500) of DNA from a skin biopsy of a patient with a monoclonal pattern (DNAc) into DNA from
a normal donor with a polyclonal pattern were performed.
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makes this technique a reliable routine diagnostic
procedure (5, 25).
Using an identical protocol, Dippel et al. (5) detected
a dominant TCR-c clone in 76% of samples of
advanced stage CTCL. In our study, we detected a
dominant clone in 68% of the samples. Eight of the
biopsies were diagnosed as SM-TCL. In this group,
62% of analysed samples presented a monoclonal peak
when the PCR product was visualized with GSA. In the
MF group (n~16) the presence of mono clonal a peak
was determined in 69% of the samples. These similar
results can probably be explained by the difference in
the number of cases of the two entities analysed (8 cases
of SM-TCL and 16 cases of MF).
Dippel et al. (5) estimated that the in vitro sensitivity
of the method for detecting a monoclonal population
admixed in a polyclonal population of human tonsillar
cells was 6%. However, additional dilution assays of
tumoral DNA with germinal DNA increased the
sensitivity to 1%. Our dilution assays with this PCR-
GSA method obtained a sensitivity of 2% when clonal
DNA was diluted with a polyclonal DNA sample
(Fig. 3). These results confirm the greater methodo-
logical sensitivity of GSA compared with techniques
such as PAGE, AGGE or SSCP (7, 23). Consequently,
when this technique is used to visualize PCR products
from samples with relatively few contaminating lym-
phocytes (for example skin biopsies), an increase in
sensitivity can be expected.
Direct sequencing was performed in cases showing
discrete bands by PCR-AGGE or PCR-PAGE and
negative results with PCR-GSA. All cases with a
‘‘positive result’’ by PCR-AGGE or PCR-PAGE and
negative with PCR-GSA turned out to be false-positive
results after performing sequencing. Only in five cases
was a monoclonal T-cell proliferation detected by PCR-
GSA that was not evident by PCR-PAGE. In these
cases PCR-GSA analysis was repeated three times and
direct sequencing confirmed the presence of a clonal
T-cell proliferation. All these results confirm that GSA
is a simpler, faster and more specific technique than
PAGE in detecting dominant clones. Other authors
confirm that the study of clonality using fluorescence
systems, e.g. fragment analysis, lightcycler or GSA,
is the most sensible, accurate and specific way for
detection of a monoclonal peak in samples with little
lymphoid infiltration (6, 7, 8, 23, 25, 26).
In our opinion, PCR-GSA is one of the most
effective methods for determining the clonality in skin
biopsies. Nevertheless, only continued studies per-
formed in parallel with a different PCR technique
will permit the exact role of the different method
variants to be clarified in the diagnosis of cutaneous
T-cell lymphoproliferative disorders (6, 7, 22, 25, 26).
Taking into account our results, we consider that
TCR gene rearrangement detected by PCR-GSA
amplification could in the near future become a routine
primary screening test for the detection of dominant
clones in the evaluation of cutaneous lymphoprolifera-
tive disorders.
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